EnteroMedics Appoints CEO
This article was originally published in Scrip
Executive Summary
EnteroMedics Inc., a company developing medical devices, has appointed Dan Gladney president and CEO – effective Nov. 16, 2015. Gladney has also been appointed to the company's board. Current president, CEO and chair of EnteroMedics, Mark Knudson, will remain its executive chair until the beginning of 2016, when he will become non-executive chair of the company's board. Most recently Gladney was director and CEO of Lanx Inc., a medical device company, which was later acquired by Biomet Inc. Prior to Lanx, Gladney was healthcare operating partner at Norwest Equity Partners and prior to this, he was president and CEO of various companies including Heart Leaflet Technologies and ACIST Medical Systems, both of which were acquired by The Bracco Group.